The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

If you are struggling to find a career that fits your personality, drive, goals in life, you might want to look at becoming a ...

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.

ICPI WEEK 2025, a comprehensive event bringing together component and materials companies across pharmaceuticals, biotech, ...

NexusTek, a leading provider of secure, scalable IT solutions, has announced the expansion of its Secure by Design portfolio ...

A biotech company integrating of AI and synthetic biology to design safer and more effective antibody therapeutics.

A developer that specializes in office to lab conversions secured the largest life science lease of 2025 in Boston with a ...

Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...

This new approach to lab space is emblematic of a broader trend in real estate: the conversion of under-utilised office space ...

This strategic investment forms part of TDB’s broader vision to advance indigenous, sustainable technologies aligned with ...